INDSWIFT LABORATORIES Financial Statement Analysis
|
||
The Revenues of INDSWIFT LABORATORIES have increased by 16.23% YoY .
The Earnings Per Share (EPS) of INDSWIFT LABORATORIES has increased by Positive YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
INDSWIFT LABORATORIES Last 5 Annual Financial Results
[BOM: 532305|NSE : INDSWFTLAB]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹1,207 Cr | ₹1,039 Cr | ₹891 Cr | ₹780 Cr | ₹757 Cr |
Expenses | ₹978 Cr | ₹843 Cr | ₹709 Cr | ₹636 Cr | ₹630 Cr |
Operating Profit (Excl OI) | ₹229 Cr | ₹196 Cr | ₹183 Cr | ₹143 Cr | ₹126 Cr |
Other Income | ₹34 Cr | ₹43 Cr | ₹23 Cr | ₹33 Cr | ₹37 Cr |
Interest | ₹92 Cr | ₹96 Cr | ₹100 Cr | ₹107 Cr | ₹92 Cr |
Depreciation | ₹57 Cr | ₹131 Cr | ₹87 Cr | ₹90 Cr | ₹104 Cr |
Profit Before Tax | ₹87 Cr | ₹13 Cr | ₹18 Cr | ₹-20 Cr | ₹50 Cr |
Profit After Tax | ₹48 Cr | ₹-2.15 Cr | ₹-3.15 Cr | ₹-21 Cr | ₹29 Cr |
Consolidated Net Profit | ₹48 Cr | ₹-2.15 Cr | ₹-3.15 Cr | ₹-21 Cr | ₹29 Cr |
Earnings Per Share (Rs) | ₹8.06 | ₹-0.36 | ₹-0.53 | ₹-3.59 | ₹6.09 |
PAT Margin (%) | 3.94 | -0.21 | -0.35 | -2.71 | 3.81 |
ROE(%) | 10.61 | -0.54 | -0.78 | -5.56 | 8.99 |
ROCE(%) | 13.25 | 7.88 | 8.31 | 5.97 | 9.25 |
Total Debt/Equity(x) | 1.71 | 2.33 | 2.56 | 2.48 | 3.21 |
Key Financials |
||
Market Cap | : | ₹ 745.8 Cr |
Revenue (TTM) | : | ₹ 1,003.7 Cr |
Net Profit(TTM) | : | ₹ 291.2 Cr |
EPS (TTM) | : | ₹ 49.3 |
P/E (TTM) | : | 2.6 |
Industry Peers & Returns | 1W | 1M | 1Y |
INDSWIFT LABORATORIES | -4.2% | -17.6% | 41.9% |
SUN PHARMACEUTICAL INDUSTRIES | -2% | 4.3% | 65.1% |
CIPLA | -2.9% | -1.8% | 39.5% |
DR REDDYS LABORATORIES | -1.8% | -2.2% | 20.6% |
ZYDUS LIFESCIENCES | -1.6% | -6.3% | 73.8% |
DIVIS LABORATORIES | -0.5% | 6.4% | 44.2% |
INDSWIFT LABORATORIES Revenues
[BOM: 532305|NSE : INDSWFTLAB]
Y-o-Y | 16.23 % |
5 Yr CAGR | 12.39 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹1,207 Cr | 16.23 | |
Mar2022 | ₹1,039 Cr | 16.54 | |
Mar2021 | ₹891 Cr | 14.33 | |
Mar2020 | ₹780 Cr | 3.05 | |
Mar2019 | ₹757 Cr | - |
INDSWIFT LABORATORIES Operating Profit
[BOM: 532305|NSE : INDSWFTLAB]
Y-o-Y | 17.16 % |
5 Yr CAGR | 16.11 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹229 Cr | 17.16 | |
Mar2022 | ₹196 Cr | 7.01 | |
Mar2021 | ₹183 Cr | 27.41 | |
Mar2020 | ₹143 Cr | 13.76 | |
Mar2019 | ₹126 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 0.80 % |
5 Yr CAGR | 3.30 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 18.98% | 0.80 | |
Mar2022 | 18.83% | -8.19 | |
Mar2021 | 20.51% | 11.47 | |
Mar2020 | 18.4% | 10.38 | |
Mar2019 | 16.67% | - |
INDSWIFT LABORATORIES Profit After Tax
[BOM: 532305|NSE : INDSWFTLAB]
Y-o-Y | Positive |
5 Yr CAGR | 13.24 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹48 Cr | Positive | |
Mar2022 | ₹-2.15 Cr | Negative | |
Mar2021 | ₹-3.15 Cr | Negative | |
Mar2020 | ₹-21 Cr | Negative | |
Mar2019 | ₹29 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Positive |
5 Yr CAGR | 0.84 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 3.94 % | Positive | |
Mar2022 | -0.21 % | Negative | |
Mar2021 | -0.35 % | Negative | |
Mar2020 | -2.71 % | Negative | |
Mar2019 | 3.81 % | - |
INDSWIFT LABORATORIES Earnings Per Share (EPS)
[BOM: 532305|NSE : INDSWFTLAB]
Y-o-Y | Positive |
5 Yr CAGR | 7.26 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹8.06 | Positive | |
Mar2022 | ₹-0.36 | Negative | |
Mar2021 | ₹-0.53 | Negative | |
Mar2020 | ₹-3.59 | Negative | |
Mar2019 | ₹6.09 | - |
INDSWIFT LABORATORIES Return on Capital Employed (ROCE)
[BOM: 532305|NSE : INDSWFTLAB]
Y-o-Y | 68.15 % |
5 Yr CAGR | 9.40 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 13.25% | 68.15 | |
Mar2022 | 7.88% | -5.17 | |
Mar2021 | 8.31% | 39.20 | |
Mar2020 | 5.97% | -35.46 | |
Mar2019 | 9.25% | - |
INDSWIFT LABORATORIES Share Price vs Sensex
Current Share Price | : | ₹126.2 |
Current MarketCap | : | ₹ 745.8 Cr |
Updated EOD on | : | Oct 04,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDSWIFT LABORATORIES | -4.2% |
-17.6% |
41.9% |
SENSEX | -4.8% |
-1.1% |
24.7% |
INDSWIFT LABORATORIES related INDICES
You may also like the below Video Courses
FAQ about INDSWIFT LABORATORIES Financials
How the annual revenues of INDSWIFT LABORATORIES have changed ?
The Revenues of INDSWIFT LABORATORIES have increased by 16.23% YoY .
How the Earnings per Share (EPS) of INDSWIFT LABORATORIES have changed?
The Earnings Per Share (EPS) of INDSWIFT LABORATORIES has increased by Positive YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs